DOI:

Discover the new country in the Valve for Life initiative, Portugal.

Discover the new country in the Valve for Life initiative, Portugal.

Keep up to date on what has been achieved so far, the challenges and expectations for 2017

Rui Campante Teles, APIC President

The Portuguese population is one of the oldest in Europe. Currently, there are around one million individuals over the age of 75. Around 3.4% of this population present with severe aortic stenosis, with about 75% being symptomatic. It is estimated that in 2015 only about 19% of potential beneficiaries actually received TAVI, and the TAVI/AVR ratio is as low as 1:6 compared to several other European countries which have already reached rates of 1:1.

There were 27 catheterisation laboratories in Portugal in 2016 with 95% of the TAVI activity performed in public hospitals. Most centres with fully operational catheterisation laboratories are part of the public health system and are thus financed by the yearly state budget for healthcare.

After the launch of the Valve for Life initiative in 2015 in Poland and France, it was decided to extend the initiative to Portugal at the beginning of 2017 under the umbrella of the Portuguese Society of Cardiology. The Oversight Committee of the initiative is confident that it can promote the use of this technology in Portugal, increasing the number of TAVI procedures. The efforts of this initiative seem promising and the prospect of duplicating the success of the other participating countries seems realistic.

In Portugal, one of the first objectives of the initiative will be to raise public awareness of the symptoms of valvular heart disease and aortic stenosis while underlining the benefits of currently available treatments. This will allow an increase in the diagnosis of the disease, eventually helping to improve access to treatment. At the same time, it will ensure hospital and cathlab capacity and funding while increasing research and analysis of scientific evidence, including clinical studies for approaches to sedation. A variety of surveys will be undertaken along with a public media campaign. Educational and other meetings and events will be planned. We are also in contact with the Portuguese Medical Association and engaged in meeting with the relevant state health officials.

Rui Campante Teles, FESC

President, APIC- Associação Portuguesa de Intervenção Cardiovascular

VFL Champions: Lino Patrício and Rui Campante Teles

Contact details: APIC - Associação Portuguesa de Intervenção Cardiovascular, Campo Grande 28, 13º, 1700-093 Lisboa, Portugal

E-mail: [email protected]

Webpage: www.valveforlife.pt

NEWS

The spotlight for the ESC Congress 2017 is on “40 years of PCI”! Young clinicians can submit their clinical cases by 1 March 2017 with the late-breaking science submissions open early March. Check it out!

Join the EAPCI Young LinkedIn group: boost your network and stay informed on educational opportunities all year long!

Learn more on EAPCI and its activities on: www.escardio.org/eapci

Volume 12 Number 14
Feb 20, 2017
Volume 12 Number 14
View full issue

On the same subject

Editorial

10.4244/EIJ-E-23-00052 Mar 18, 2024
Comparative preclinical assessment of drug-coated balloons: a blessing and a curse for clinical translation
Joner M and Wild L
free

Debate

10.4244/EIJ-E-24-00005 Mar 18, 2024
Ischaemic and viability testing for guiding PCI are overrated: pros and cons
McEntegart M et al
free

Original Research

10.4244/EIJ-D-23-00725 Mar 18, 2024
A systematic algorithm for large-bore arterial access closure after TAVI: the TAVI-MultiCLOSE study
Rosseel L et al

Original Research

10.4244/EIJ-D-23-00783 Mar 18, 2024
Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure
Meier D et al
Trending articles
281.88

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
243.2

State of the art

10.4244/EIJ-D-21-01117 Sep 20, 2022
Recanalisation of coronary chronic total occlusions
Di Mario C et al
free
208.35

State-of-the-Art Review

10.4244/EIJ-D-21-01034 Jun 3, 2022
Management of in-stent restenosis
Alfonso F et al
free
168.7

Translational research

10.4244/EIJ-D-21-00824 May 15, 2022
Bench test and in vivo evaluation of longitudinal stent deformation during proximal optimisation
Toth GG et al
free
167.05

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
151.03

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
118

Translational research

10.4244/EIJ-D-22-00718 Jun 5, 2023
Preclinical evaluation of the degradation kinetics of third-generation resorbable magnesium scaffolds
Seguchi M et al
110.35

Viewpoint

10.4244/EIJ-E-22-00007 May 15, 2022
TAVI at 20: how a crazy idea led to a clinical revolution
Eltchaninoff H et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved